Use of full 5-HT1A agonists to inhibit opiate / opioid-induced respiratory depression

摘要

The invention relates to the use of full-length 5-HT1-A1 agonists for the preparation of medicaments for inhibiting opiate / opioid-induced respiratory depression in humans.